Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MedImmune Inc. preclinical data

By WIR Staff | Oct 18, 2004 | 7:00 AM GMT

Researchers published in the Journal of Virology

Read the full 76 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE